With the business potentially at an important milestone, we thought we'd take a closer look at DEMIRE Deutsche Mittelstand Real Estate AG's future prospects. DEMIRE Deutsche Mitte ...
With the business potentially at an important milestone, we thought we'd take a closer look at Alithya Group Inc.'s (TSE:ALYA) future prospects. Alithya Group Inc. provides strategy and digital ...
Completed ahead of schedule, boosting annual passenger capacity more than 65 million at the World's Best Airport ...
With the business potentially at an important milestone, we thought we'd take a closer look at Glaukos Corporation's (NYSE:GKOS) future prospects. Glaukos Corporation, an ophthalmic pharmaceutical and ...
From its launch in 2010 to its acquisition by Facebook in 2012 and its 600 million-user milestone, Instagram has grown into a social media phenomenon. WebsiteBuilder.org, which helps people figure out ...
With the business potentially at an important milestone, we thought we'd take a closer look at BlueBet Holdings ...
The worst long-term complication of measles is a form of delayed encephalitis called subacute sclerosing panencephalitis ...
Streamline the process of accreditation, create multi-modal communications and effectively manage data by harnessing the ...
The robotics start-up co-founded by former Huawei 'Genius Youth' recruits has an ambitious 5,000-unit production target, far ...
Foxconn Technology Group, the world's largest electronics contract manufacturer and major iPhone supplier for Apple, launched ...
Empagliflozin is an SGLT-2 (Sodium-Glucose Co-Transporter-2) inhibitor indicted for use in the treatment of type-2 diabetes mellitus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback